Biofidelity to present ASPYRE®-Lung data at AACR 2024
/PRNewswire/ -- Biofidelity, a revolutionary genomic technology company dedicated to bringing the benefits of precision medicine to patients around the world,...
Stay updated with breaking news from Barnaby Balmforth. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Biofidelity, a revolutionary genomic technology company dedicated to bringing the benefits of precision medicine to patients around the world,...
Genomic tech company Biofidelity, which has operations in Cambridge and North Carolina commercialising precision medicine for patients worldwide, has raised $24 million growth capital.
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Cambridge Cluster Life Sciences companies continue to grow stronger and more globally influential and have the opportunity to demonstrate their turnkey excellence in the 2023-24 Business Weekly Awards.
/PRNewswire/ -- Biofidelity today announced the commercial launch of its ASPYRE®-Lung RUO reagent product....